Valganciclovir as Add-On Therapy Modifies the Frequency of NK and NKT Cell Subpopulations in Disseminated Kaposi Sarcoma Patients

SIMPLE SUMMARY: Kaposi sarcoma is one disease that develops in people living with HIV with severe immunosuppression and impacts morbidity and associated mortality. This disease is currently treated with antiretroviral therapy and chemotherapy agents that can further contribute to immunosuppression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores-Gonzalez, Julio, Ramon-Luing, Lucero A., Ocaña-Guzman, Ranferi, Buendia-Roldan, Ivette, Islas-Muñoz, Beda, Volkow-Fernández, Patricia, Chavez-Galan, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773484/
https://www.ncbi.nlm.nih.gov/pubmed/35053573
http://dx.doi.org/10.3390/cancers14020412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773484/
https://www.ncbi.nlm.nih.gov/pubmed/35053573
http://dx.doi.org/10.3390/cancers14020412

Ejemplares similares